{"entity":{"type":"insider","cik":"0001316918","url":"/insider/0001316918","json_url":"/insider/0001316918.json","name":"Sanderling Venture Partners V Co Investment Fund, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":6,"first":"2005-02-17","last":"2012-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Sanderling Venture Partners V Co Investment Fund, LP","source":"filing","n_filings":6,"first_seen":"2005-02-17","last_seen":"2012-01-11"}],"transactions":[{"id":9268029,"accession":"0001209191-12-003316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-003316","line_url":"/filing/0001209191-12-003316#line-2","is_derivative":false,"issuer_cik":"0001512540","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001512540","owner_cik":null,"owner_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V BIOMEDICAL LP; SANDERLING V LTD PARTNERSHIP; Sanderling V Strategic Exit Fund LP; Sanderling VI Beteiligungs GmbH & Co KG; Sanderling VI Limited Partnership; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197800.0,"shares_display":"197,800","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":625048.0,"total_display":"625,048.00","total_whole":"625,048","shares_owned_after":831461.0,"shares_owned_after_display":"831,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2012-01-11","scope":"insider"},{"id":8820621,"accession":"0001209191-11-062937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-062937","line_url":"/filing/0001209191-11-062937#line-2","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Sanderling VI Beteiligungs GmbH & Co KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling VI Limited Partnership; SANDERLING V LTD PARTNERSHIP; SANDERLING V BIOMEDICAL LP; Sanderling V Strategic Exit Fund LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"Sanderling VI Beteiligungs GmbH & Co KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217800.0,"shares_display":"217,800","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":688248.0,"total_display":"688,248.00","total_whole":"688,248","shares_owned_after":871461.0,"shares_owned_after_display":"871,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-22","scope":"insider"},{"id":9268028,"accession":"0001209191-12-003316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-003316","line_url":"/filing/0001209191-12-003316#line-1","is_derivative":false,"issuer_cik":"0001512540","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001512540","owner_cik":null,"owner_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V BIOMEDICAL LP; SANDERLING V LTD PARTNERSHIP; Sanderling V Strategic Exit Fund LP; Sanderling VI Beteiligungs GmbH & Co KG; Sanderling VI Limited Partnership; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197800.0,"shares_display":"197,800","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":632960.0,"total_display":"632,960.00","total_whole":"632,960","shares_owned_after":633661.0,"shares_owned_after_display":"633,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-20","filed_date":"2012-01-11","scope":"insider"},{"id":8820619,"accession":"0001209191-11-062937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-062937","line_url":"/filing/0001209191-11-062937#line-1","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Sanderling VI Beteiligungs GmbH & Co KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling VI Limited Partnership; SANDERLING V LTD PARTNERSHIP; SANDERLING V BIOMEDICAL LP; Sanderling V Strategic Exit Fund LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"Sanderling VI Beteiligungs GmbH & Co KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217800.0,"shares_display":"217,800","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":696960.0,"total_display":"696,960.00","total_whole":"696,960","shares_owned_after":653661.0,"shares_owned_after_display":"653,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-20","filed_date":"2011-12-22","scope":"insider"},{"id":8867947,"accession":"0001209191-11-007953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-007953","line_url":"/filing/0001209191-11-007953#line-1","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Sanderling Venture Partners V Co Investment Fund, LP; Sanderling Venture Partners VI Co Investment Fund LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners V, LP; Sanderling VI Beteiligungs GmbH & Co KG; Sanderling VI Limited Partnership; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V LTD PARTNERSHIP; SANDERLING V BIOMEDICAL LP","owner_display_name":"Sanderling Venture Partners V Co Investment Fund, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":785417.0,"shares_display":"785,417","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":4712502.0,"total_display":"4,712,502.00","total_whole":"4,712,502","shares_owned_after":785417.0,"shares_owned_after_display":"785,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-04","filed_date":"2011-02-08","scope":"insider"},{"id":4013468,"accession":"0001104659-08-051529","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-08-051529","line_url":"/filing/0001104659-08-051529","is_derivative":false,"issuer_cik":"0001113784","issuer_name":"CARDIONET INC","issuer_ticker":"BEAT","issuer_name_source":null,"issuer_url":"/issuer/0001113784","owner_cik":null,"owner_name":"Sanderling VI Beteiligungs GmbH & Co KG; Sanderling Venture Partners IV, L.P.; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling VI Limited Partnership; SANDERLING V LTD PARTNERSHIP; Sanderling Ventures Management VI; SANDERLING VENTURES MANAGEMENT V; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"Sanderling VI Beteiligungs GmbH & Co KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":610444.0,"shares_display":"610,444","price_per_share":26.5,"price_display":"26.50","price_state":"stated","total_value":16176766.0,"total_display":"16,176,766.00","total_whole":"16,176,766","shares_owned_after":318705.0,"shares_owned_after_display":"318,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-06","filed_date":"2008-08-08","scope":"insider","n_lines":10},{"id":3848962,"accession":"0001104659-06-015504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-06-015504","line_url":"/filing/0001104659-06-015504#line-1","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"FAVRILLE INC","issuer_ticker":"FVRL","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Middleton, McNeil & Mills Associates V, LLC; SANDERLING V BIOMEDICAL LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V LTD PARTNERSHIP; Sanderling Venture Partners V, LP; Sanderling Venture Partners V Co Investment Fund, LP; SANDERLING VENTURES MANAGEMENT V","owner_display_name":"Middleton, McNeil & Mills Associates V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19011.0,"shares_display":"19,011","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":99997.86,"total_display":"99,997.86","total_whole":"99,998","shares_owned_after":2773091.0,"shares_owned_after_display":"2,773,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-07","filed_date":"2006-03-09","scope":"insider"},{"id":1641318,"accession":"0001019687-05-000466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001019687-05-000466","line_url":"/filing/0001019687-05-000466#line-2","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"FAVRILLE INC","issuer_ticker":"FVRL","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"SANDERLING VENTURES MANAGEMENT V; Sanderling Venture Partners VI Co Investment Fund LP; SANDERLING V BIOMEDICAL LP; Sanderling Venture Partners V, LP; SANDERLING V LTD PARTNERSHIP; SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Middleton, McNeil & Mills Associates V, LLC","owner_display_name":"SANDERLING VENTURES MANAGEMENT V","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1142857.0,"shares_display":"1,142,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":7999999.0,"total_display":"7,999,999.00","total_whole":"7,999,999","shares_owned_after":3182652.0,"shares_owned_after_display":"3,182,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-07","filed_date":"2005-02-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001235007","name":"ENDOCYTE INC","url":"/issuer/0001235007","role":"Ten percent owner","n_filings":3,"first_seen":"2011-02-08","last_seen":"2012-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001113784","name":"CARDIONET INC","url":"/issuer/0001113784","role":"Ten percent owner","n_filings":1,"first_seen":"2008-08-08","last_seen":"2008-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001285701","name":"FAVRILLE INC","url":"/issuer/0001285701","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2005-02-17","last_seen":"2006-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001316918","retrieved_at":"2026-08-23T11:17:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}